Navigation Links
Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
Date:3/24/2011

NATICK, Mass., March 24, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System, the world's first rechargeable SCS device for chronic pain management.  The Clik Anchor features an innovative locking system designed to improve lead anchoring speed and consistency.  Locking into place on the lead with a simple turn of a hex wrench, it provides tactile and audible confirmation for physicians that the lead is secured.  The Company is introducing the Clik Anchor at the American Academy of Pain Medicine Annual Meeting, which begins today in Washington, D.C.

"The Clik Anchor is easy to use and gives me confidence that the lead is secure," said Salim Hayek, M.D., Ph.D., of the University Hospitals Case Medical Center in Cleveland, Ohio.  "This new product will benefit my patients and my practice with simpler, more consistent lead anchoring."

According to the National Center for Health Statistics, pain is the most common reason Americans seek medical treatment, and an estimated 26 million Americans experience frequent back pain.  Tens of thousands of patients with chronic pain have found that SCS systems help them manage their pain.  Spinal Cord Stimulation is a reversible therapy that manages pain through an implantable pulse generator and external devices that control therapy and charge an implant.

Boston Scientific's Precision Plus SCS System, powered by SmoothWave™ Technology, masks pain signals by delivering independently controlled pulses of electricity through SCS leads.  Anchors are designed to secure leads and minimize unwanted migration.  

"With approval and launch of the Clik Anchor, we have added six new products to our Neuromod
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific to Webcast Analyst Event
2. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
3. Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System
4. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
5. Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech
6. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
7. Nektar Therapeutics President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston
8. Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India
9. Boston Scientific to Participate in 2011 RBC Capital Markets Healthcare Conference
10. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
11. Boston Scientific Establishes Endowment for Donald S. Baim, M.D., Scholarship at Yale School of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... With advancements in neurological and functional ... seeing new growth, according to Kalorama Information. Though ... the majority of market volume, newer 3T systems ... are creating opportunities for more sophisticated applications. The medical ... a rate of 4%, with world market revenues ...
(Date:12/17/2014)... ANGELES , Dec. 17, 2014  ImmunoCellular ... the US Patent and Trademark Office (USPTO) has ... ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting six ... The claims of US Patent No. 8,871,211, which ... neural cancer by administering a dendritic cell composition ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, 2014 ... and Integrated Clinical Trial Services, LLC (ICTS), two ... clinical trials announce that they have formed a ... (i-CTMS). i-CTMS will provide a broad range of ... and medical device companies. i-CTMS will ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... June 25 Perrigo Company (Nasdaq: PRGO ; TASE) announced ... present at the Oppenheimer 10th Annual Consumer, Gaming, Lodging & Leisure Conference ... at the Four Seasons Hotel in Boston .  The presentation will ... , , ...
... 25 PartsSource, the world,s #1 ebusiness solution ... has been honored with the 2010 Manny Award for ... its 13th year, the Manny Award program is committed ... companies for their innovations and best practices. This was the ...
Cached Medicine Technology:Perrigo Company to Present at the Oppenheimer 10th Annual Consumer, Gaming, Lodging and Leisure Conference 2PartsSource Wins 2010 Manny Award for Workplace Environment 2
(Date:12/17/2014)... A group of 127 scientists sent an “open ... to a recent statement by the center that was highly ... the efficacy of all brain exercises. , Signatories to the ... the center’s statement critical of brain exercise companies that overstate ... its case, in a document it had entitled “A Consensus ...
(Date:12/17/2014)... No matter how far modern medicine advances, ... head louse parasite—a common childhood malady and a source ... six and twelve million individuals will suffer an infestation. ... company comes to the rescue, providing an all-natural treatment ... track record of customer service, and effectiveness in getting ...
(Date:12/17/2014)... Mamaroneck, NY (PRWEB) December 17, 2014 ... man who recently brought videos of MIT economist and ... and best-selling author James O’Keefe conducted the interview, which ... “Rich” stated that there was intentional mislabeling in the ... agenda in the bill: A two-hundred-and-fifty billion dollar per ...
(Date:12/17/2014)... Alan Mozes HealthDay Reporter , ... of infectious diseases, one worrisome phenomenon is when an illness ... process -- known as zoonosis -- is not uncommon and ... that an animal-borne disease might make inroads into the human ... development -- and the culprits in this case were guinea ...
(Date:12/17/2014)... get more fruits and vegetables at school than they do ... is true for students from wealthier families. These findings ... a healthy boost to poor students, diets, according to the ... students all ate a similar amount of fruits and vegetables ... recently in the journal Preventive Medicine . ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Poor Students Eat Healthier Foods at School, Study Finds 2
... from early magnetic resonance imaging, according to the ... in Canada MRI technology could determine //if performing ... that trauma-induced spinal cord compression on MRIs predict ... spinal cord compression. However, unless surgeons are fairly ...
... condition that affects primarily women. The condition is characterized ... rest and often worsens with physical activity. The cause ... diagnostic tests or cures. A recent study explains that ... for developing chronic fatigue later in life. ,Researchers ...
... a connection between the use of two of the ... reduced risk for // bone fractures. Beta-blockers are commonly ... chest pain, and abnormal heart rhythms. Some heart attack ... attack. Diuretics are used to remove excess water from ...
... undertaken at Wake Forest University Baptist Medical Center researcher ... suggested //that the type of progestin in hormonal therapy ... ,At an annual meeting of the North American ... Williams who is the lead investigator from Wake Forest ...
... Retinitis pigmentosa, a progressive eye disease targeting the light-collecting ... worldwide and can cause // vision loss. Researchers say ... docosahexaenoic acid to vitamin A therapy may not provide ... followed 221 patients, ranging in age from 18 to ...
... Researchers have found that chemotherapy improves survival and reduces the ... // (cancer that has not spread beyond the ovary). ... confined to the ovaries, when five-year survival is 85 percent. ... patients, since eight in 10 patients are adequately treated by ...
Cached Medicine News:Health News:Hormone therapy may affect heart attack severity in women 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: